Your browser doesn't support javascript.
loading
Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study.
Gao, Lei; Zhang, Haoran; Xin, Henan; Liu, Jianmin; Pan, Shouguo; Li, Xiangwei; Guan, Ling; Shen, Fei; Liu, Zisen; Wang, Dakuan; Guan, Xueling; Yan, Jiaoxia; Li, Hengjing; Feng, Boxuan; Cao, Xuefang; Chen, Yu; Cui, Wei; Zhang, Zongde; Ma, Yu; Chen, Xiaoyou; Zhou, Xinhua; Jin, Qi.
Afiliação
  • Gao L; MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology and Center for Tuberculosis, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Zhang H; These authors contributed equally to this work.
  • Xin H; These authors contributed equally to this work.
  • Liu J; MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology and Center for Tuberculosis, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Pan S; These authors contributed equally to this work.
  • Li X; MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology and Center for Tuberculosis, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Guan L; These authors contributed equally to this work.
  • Shen F; The Sixth People's Hospital of Zhengzhou, Zhengzhou, China.
  • Liu Z; These authors contributed equally to this work.
  • Wang D; Center for Diseases Control and Prevention of Zhongmu, Zhongmu, China.
  • Guan X; These authors contributed equally to this work.
  • Yan J; MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology and Center for Tuberculosis, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Li H; The Sixth People's Hospital of Zhengzhou, Zhengzhou, China.
  • Feng B; The Sixth People's Hospital of Zhengzhou, Zhengzhou, China.
  • Cao X; Center for Diseases Control and Prevention of Zhongmu, Zhongmu, China.
  • Chen Y; Center for Diseases Control and Prevention of Zhongmu, Zhongmu, China.
  • Cui W; The Sixth People's Hospital of Zhengzhou, Zhengzhou, China.
  • Zhang Z; Center for Diseases Control and Prevention of Zhongmu, Zhongmu, China.
  • Ma Y; MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology and Center for Tuberculosis, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Chen X; MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology and Center for Tuberculosis, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Zhou X; MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology and Center for Tuberculosis, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Jin Q; The Sixth People's Hospital of Zhengzhou, Zhengzhou, China.
Eur Respir J ; 52(6)2018 12.
Article em En | MEDLINE | ID: mdl-30361241
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rifampina / Tuberculose Latente / Isoniazida Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rifampina / Tuberculose Latente / Isoniazida Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article